News

The double-blind, placebo-controlled dose-escalating trial includes four groups of 10 subjects each to assess the safety of multiple doses at escalating concentrations of RGN-352 injected into the blood

This five-year renewable agreement gives DePuy Mitek exclusive distribution rights for both products in all of South America, Central America, the Caribbean and Mexico. DePuy Mitek currently distributes

In this position, Mr Connor will guide the software development roadmap for Phoenix Data Systems’s (PDS) express suite of eClinical technology products. As the director of product development,

Enlyten Medical Technologies is based in the Netherlands with operations in Israel and offices in the US. Mr Raz served as CEO and chairman in the main defense

Mr Goolsby agreed to provide consulting services to the company until January 2009. Richard Rusk, currently vice president, treasurer and controller of the company, will assume the role

Mr Sachs will be responsible for the creation and execution of Carestream Health’s merger and acquisition strategy and for the development of strategic growth plans. Most recently, Mr

The combination of BTG and Protherics is intended to create a profitable specialty pharmaceuticals business with significant revenues and royalties from both marketed products and partnered development programs.

The results confirm a continued benefit of initiating treatment with Betaseron shortly after the first event. The study also demonstrated that early treatment with Betaseron had a beneficial

Previously, the company announced the trial met its primary endpoint with a significantly greater proportion of people taking Fampridine-SR having a consistent improvement in walking speed compared to